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Abstract
The ability to label, visualize, and manipulate subsets of neurons is critical for elucidating the structure and function of
individual cell types in the brain. Enhancer trapping has proved extremely useful for the genetic manipulation of selective
cell types in Drosophila. We have developed an enhancer trap strategy in mammals by generating transgenic mice with
lentiviral vectors carrying single-copy enhancer-detector probes encoding either the marker gene lacZ or Cre recombinase.
This transgenic strategy allowed us to genetically identify a wide variety of neuronal subpopulations in distinct brain
regions. Enhancer detection by lentiviral transgenesis could thus provide a complementary method for generating
transgenic mouse libraries for the genetic labeling and manipulation of neuronal subsets.
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Introduction
Mammalian brains contain a bewildering variety of different
classes of neurons. Interestingly, it is still not known how many
different neuronal types exist in the mouse or rat brain, the most
commonly used laboratory animals. The number of distinct
neuronal types steadily increases as new analyses and techniques
better differentiate those using combined anatomical, electrophys-
iological, and genetic criteria [1,2,3]. The ability to identify
specific neuronal types will be critical for understanding their
contribution towards brain function and behavior [4]. Moreover,
to investigate the function of genetically defined subsets of cells, it
is necessary not only to visualize them, but also to selectively
manipulate their gene expression. Transgenic animals expressing
fluorescent markers in neuronal subsets [5] have proven very
useful for in vivo imaging and electrophysiology. However, there is
currently only a limited number of mouse lines that express visible
markers in subsets of neurons [5,6], and only a few lines can be
used for selective gene manipulation in these neuronal populations
[7]. We have developed a new mouse transgenic strategy in which
expression of the recombinase Cre depends on enhancer de-
tection, with the goal of creating libraries of transgenic mice with
the ability to visualize and manipulate genes in selective subsets of
neurons. To achieve this goal, we used lentiviral transgenesis to
deliver enhancer-detection probes into single-cell mouse embryos.
Lentiviruses integrate preferentially into gene-rich regions of the
genome [8], thereby increasing the chance that a transgene
insertion will be activated by nearby enhancers. The strategy of
enhancer detection relies on a gene of choice present within
a transgenic probe whose transcription depends on where the
probe integrates in the genome. In eukaryotic cells, gene
expression depends on the presence of cis-DNA sequences that
regulate the rate of transcription of the gene and transcription
factors that recognize them [9]. The two major classes of DNA cis-
regulatory transcriptional elements are long-range and short-range
elements. Short-range regulatory elements, called promoters, are
located immediately upstream of the gene they regulate. In
contrast, long-range regulatory elements can be located either
within introns, upstream or downstream of the transcription start
site, sometimes up to hundreds of kilobases away from the gene
whose activity they regulate [10]. These distant regulatory
elements can either have a positive or a negative effect on
transcription, and they are designated as enhancers or silencers,
respectively. In line with the traditional nomenclature used in
enhancer trapping, here we will refer to both of these elements as
enhancers for simplicity. By themselves, neither enhancers nor
promoters are sufficient to drive transcription. The functional
expression of genes requires the combined activity of enhancers
and promoters, situated in a specific configuration with respect to
the gene they regulate. The strategy of enhancer detection is based
on the requirement of promoters to be activated by enhancers to
achieve expression of the genes they regulate [11] (Figure 1). We
have engineered lentiviral vectors encoding enhancer detection
probes that allowed efficient generation of transgenic mice
selectively expressing Cre under the influence of enhancers located
in the vicinity of the chromosomal integration site. We demon-
strated the utility of these transgenic mice for the identification of
specific neuronal classes and for their electrophysiological charac-
terization. In addition, these mice can be used to perform Cre-
mediated gene manipulation in selective neuronal types. Our
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e38593results demonstrate that enhancer detection, a technique that has
proven extremely valuable to genetically identify and manipulate
cells in invertebrates, could provide a complementary approach to
genetically dissection of the neuronal diversity of the mouse brain.
Results
Efficient Enhancer Trapping with a lacZ Reporter
In order to test the applicability of enhancer detection by
lentiviral vectors, we first generated a lentiviral enhancer probe
containing the minimal promoter of the human heat-shock gene
68 (hsp68), which by itself has a very low basal level of activity and
must be activated by an enhancer on the same chromosome to
achieve expression of a reporter gene [12]. We then generated
transgenic mice by infecting single-cell mouse embryos with
a recombinant lentiviral vector carrying the hsp68 minimal
promoter controlling the expression of the nlacZ gene, which
contains a nuclear localization sequence. Treated embryos were
then returned to the uterus of surrogate mothers to complete
development. Transgenic founders were bred with wild type
animals to obtain a single copy of an insertion in the offspring. To
maximize the chances of obtaining animals in which single-copy
transgenes could be generated within one breeding cycle, we
titrated the lentiviral vector in our procedure so that we obtained
1–4 insertions per founder animal that could be separated by
breeding over 1–2 generations. Most animals (23 out of 25 lines)
carrying a single copy insertion displayed distinct expression
patterns in the brain when assayed by lacZ histochemistry. The
pattern of nlacZ-expressing cells in the different transgenic lines
ranged from near-ubiquitous to restricted to, for example, specific
layers in the cortex, subregions of the hippocampus, and medio-
lateral gradients within the same structure (Figure 2). We cloned
the insertion site of eight different lines by ligation-mediated PCR.
As expected from previously published works [8], four out eight
insertions were located within introns, and the remaining four
insertions were located either upstream or downstream of the
genes’ coding region (Figure 3).
The patterns of lacZ expression from the transgenic animals we
analyzed did not faithfully match that of the endogenous genes
into which it integrated. For example, transgenic line (FHZ.03,
Figure 3) had an insertion into the third intron of Npas3, a gene
mutated in rare forms of familial schizophrenia [13]. The
expression of the endogenous NPAS3 gene is broadly expressed
in the adult mouse brain [13]. In contrast the FHZ.03 transgenic
line displayed a more restricted pattern than that of the
endogenous Npas3 with layer-specific expression in the hippo-
campal dentate gyrus, and in the retrosplenial and piriform
cortices. The interaction between minimal promoters and
enhancers is specific, such that not all minimal promoters will
interact with all enhancers. Therefore, it is anticipated that in
enhancer detection strategies the expression pattern of the reporter
gene present in the detector probe may not faithfully reproduce
the expression pattern of the endogenous gene where it integrates
[10,14]. However, the appearance of patterns of expression
resulting from enhancer detection in transgenic animals that do
not faithfully reproduce those of endogenous genes could be
advantageous in many situations since some of these patterns
could label selective populations of neurons, as shown in Figure 2
and 3).
Cre-based Transgenics with a GFP Reporter
The initial experiments with the nlacZ probe confirmed the
validity of the strategy of genetic labeling of neuronal types by
enhancer detection. Although visible markers such as lacZ or
GFP are useful for the visualization of neurons, they cannot be
used for manipulation of gene expression. Selective gene
manipulation can be obtained using a Cre/loxP-system where
expression of the Cre enzyme in subsets of neurons regulates the
expression of a ‘floxed’ gene. Accordingly, we proceeded to
generate mice with an enhancer detector probe expressing Cre
under the control of the hsp68 minimal promoter.These founder
Figure 1. Generation of transgenic mice carrying a nlacZ enhancer probe under control of a hsp68 minimal promoter. Enhancer
probes integrate into different sites in the genome. Depending on the site of integration the interaction of the introduced minimal promoter and
enhancer elements of the genome results in restricted expression of the transgene.
doi:10.1371/journal.pone.0038593.g001
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crossing them with the cre-dependent GFP reporter line (Z/EG)
[15], that allows detection of recombination in neurons by
expression of cytoplasmic GFP. However, when we examined the
brains of these mice, we observed that in most cases, the
recombination patterns were too broad in the brain, and
therefore not useful for most experiments (data not shown). This
near-ubiquitous pattern of expression results from the fact that
once Cre recombines a loxP cassette in a given cell, all the
progeny of these cells will inherit the recombined loxP allele
(‘prospective’ labeling). Thus, if the hsp68-cre cassette leads to
expression in some cells during early embryonic development,
this would lead to a very high number of ‘floxed’ cells in the
brain. Consistent with this hypothesis, we observed that animals
with broad GFP expression (due to loxP recombination in the Z/
EG mice) showed sparse or no persistent Cre expression in
adulthood (data not shown).
In order to bias the specificity of Cre expression to neurons, and
to reduce the appearance of ubiquitous patterns of recombination,
we generated a lentiviral enhancer detection probe carrying cre
under the control of the minimal promoter of the thy-1.2 gene,
consisting of 310 base pairs upstream from its transcription start
site (thy1mp-cre) [16]. The thy-1.2 gene is preferentially expressed
in projection neurons in the mouse brain, and its minimal
promoter may contain elements that could restrict its activity to
neurons [17,18]. Founder transgenic animals carrying 1–4
insertions of thy1mp-cre were bred to the Cre-dependent GFP
reporter lines (Z/EG) to obtain lines with single copy insertions of
the enhancer detection probe. We observed a large diversity of
restricted recombination patterns in 16 out of 20 lines (Figure 4A).
The pattern of recombination was reproducible among animals
with the same single insertion of the enhancer probe (Figure S1).
In the hippocampus, for example, we observed that recombination
patterns were frequently restricted to specific substructures (CA1,
Figure 2. Labeling of subsets of neurons in hsp68-nlacZ lines. (A), (B) Sagittal sections of mice carrying a single copy of the hsp68-nlacZ
transgene. A large variety of subsets of neurons was labeled in eleven independent mouse lines labeled FHZ.01 to FHZ.11 ((A) bar=1.5 mm, (B)
bar=1 mm). (B1), (B2) Higher magnification views show a population of labeled cortical neurons in the frontal cortex of the brain shown in B (both
bar=100 um).
doi:10.1371/journal.pone.0038593.g002
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lines that labeled specific neuronal types, such as of olfactory
receptor neurons (FTC.07, Figure 4B) and granule cells of the
accessory olfactory bulb (FTC.13, Figure 4C). In certain cortical
areas, we observed that recombination patterns were restricted to
specific layers (Figure 4A).
Variability of Functional Properties in Neuronal Subsets
In several independent transgenic lines, cells with layer-specific
recombination in the cortex had the morphology of pyramidal
neurons. To examine whether these layer-specific transgenic lines
contained subsets of neurons defined by specific electrophysiolog-
ical properties, we selected the transgenic line FTC.08 for
fluorescence-guided whole-cell recordings that had GFP
+ neurons
in layer 2/3 in the visual cortex (V1 area, Figure 5A-D). To
determine the homogeneity of the electrophysiological properties
of the GFP
+ cells, we compared them to GFP
2 control neurons in
layer 2/3 in the same animals. We observed that in this transgenic
line the variability in some of the electrical properties of GFP
+
cells, such as frequency–current relationship or adaptation index,
was smaller in GFP
+ than in GFP
2 neurons of the same layer
(Figure 5E, F, see also Figure S2 for additional data). These
observations underscore the usefulness of the enhancer trap
approach to identify neuronal populations with defined properties.
Discussion
We have developed a genetic approach to efficiently generate
large numbers of transgenic mouse lines that selectively express
Cre in subsets of neurons based on enhancer detection. Such Cre
mouse lines can be used for fluorescence-guided recordings, gene
expression profiling, in vivo imaging, and gene manipulation. The
flexibility of the Cre-based site-specific recombination system
allows cell-type specific gene ablation [19], opto-genetic control
of neuronal activity [20] and trans-synaptic tracing of connec-
tions of genetically defined neurons [21] among other available
techniques. This flexible system could be particular useful in
cellular and system neuroscience where multiple cell-types
contribute to the function of the system. Creating these mouse
lines using the mammalian enhancer trap strategy complements
existing approaches that aim to provide neuronal-type specific
expression in transgenic animals. Transgenic mice generated with
bacterial artificial chromosomes (BACs) that express GFP or Cre
under the transcriptional regulatory elements of candidate genes
of interest, e.g. calcium binding proteins [6,7], are well suited to
characterize neuronal types that express known genes. In
contrast, the enhancer trap technique promises to yield a larger
number of recombination patterns as it benefits from the random
integration of the probe into different genomic loci, and
subsequent interaction between the promoter present in the
probe and the enhancer elements present in the genomic DNA.
This random genomic insertion pattern could be an advantage to
address some specific problems in neurobiology, such as the
classification of interneuron types in the brain. Traditionally,
classes of interneurons have been defined by the expression of
genes such as parvalbumin, calbindin, or cholecystokinin [2].
Transgenic mice have been generated expressing marker genes
under the regulatory elements that control the transcription of
these proteins, but the labeled neurons can be heterogeneous
both in their morphology and electrophysiological properties [2].
This observation suggests that the expression of single genes
could not be used to identify functionally distinct neuronal types.
Thus, it is likely that the classification of neurons will require an
intersectional strategy that is requiring the sharing of at least two
Figure 3. Labeling of subsets of neurons in different hsp68-nlacZ lines. (A) Coronal section of a mouse carrying a single copy of the hsp68-
nlacZ transgene that integrated into the coding region of the Npas3 gene (bar=1 mm). (B) The table shows the genomic insertion site of eight
mouse lines carrying a single copy of the hsp68-nlacZ transgene. (C) Sagittal sections of a mouse carrying a single copy of the hsp68-nlacZ transgene
that integrated into the coding region of the Phospholipase C-gamma1 gene. Medial to lateral sections of the brain reveal a medio-lateral expression
gradient both in the hippocampus and cerebellum (bar=1mm).
doi:10.1371/journal.pone.0038593.g003
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a particular calcium-binding protein and a specific type of ion
channel. In the enhancer detection strategy, the pattern of
expression depends on the interaction between the minimal
promoter present in the probe and the enhancer element present
in the genomic insertion site. In our nlacZ lines, the active
expression of the marker gene in the probe can be directly
detected (without the prospective labeling that occurs after Cre-
recombination). We observed that in three of them that had
insertions inside of introns (into the genes Npas3, Atp11c and
PLC-gamma), the pattern of expression of the nlacZ gene
overlapped, but was more restricted than the endogenous genes
into which it inserted. The transcription of the endogenous gene
is regulated by the interaction between multiple enhancers with
its own minimal promoter. It is known that the interaction
between enhancers and promoters shows some specificity, with
some enhancers interacting with some promoters but not others.
In our transgenic animals, transcription of the marker genes
(lacZ or cre) depends on the interaction between the minimal
promoters present in the transgenic probe (hsp68 or thy1mp) and
some, but most likely not all, the enhancers neighboring the
insertion site. Thus, it is expected that the pattern of expression
originating from the enhancer detector probe will not re-
capitulate faithfully the expression pattern of the endogenous
gene close to its insertion site, but instead, it would be biased by
the ability of the minimal promoters to interact with some of the
Figure 4. Labeling of subsets of neurons in thy1mp-cre lines. (A) Sagittal sections of mice carrying a single copy of the thy1mp-cre transgene
(lines named FTC.01-FTC.13). A large variety of subsets of neurons were labeled in eight independent mouse lines shown here (bar=2.5mm). (B)
Labeling of olfactory receptor neurons (FTC.07) (bar=250 um). (C) Labeling of granule cell neurons in the accessory olfactory bulb (FTC.13)
(bar=500um). (D) Sagittal sections of the dorsal hippocampal formation of eight different thy1mp-cre lines reveal recombination restricted to
subregions of the hippocampus (CA1, CA3 or dentate gyrus) (bar=500 um).
doi:10.1371/journal.pone.0038593.g004
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this approach, it would be possible to take advantage of enhancer
detector probes with biased minimal promoters, which will
further limit the interactions between the probe promoter and
the genomic enhancers. For example, a probe containing
a minimal promoter derived from the gad67 gene could yield
transgenic lines biased towards subsets within this population of
interneurons.
The technique of enhancer detection has been applied in
experimental animals such as Drosophila with great success [11,22].
Although a few works have described the production of transgenic
mice carrying enhancer detector probes, technical limitations have
hampered the use of this strategy [11,23]. First, transgenes
introduced by pronuclear injection in mice integrate as head-to-
tail tandem arrays of multiple copies of the same construct in
a single chromosomal location and are prone to epigenetic effects
such as repeat induced silencing [24]. Second, the application of
enhancer detection to a particular animal species requires the
ability to efficiently introduce the enhancer probe into the genome
of that animal, and previously available techniques such as gene
targeting in embryonic stem cells and pronuclear injection are
time-consuming, laborious and relatively inefficient [16,25]. In
contrast to the low success rate of approximately 10% when using
these previous techniques, introducing genes into early mouse
embryos via recombinant lentiviral vectors yields more than 80%
transgenic animals and therefore can easily be scaled up for high
throughput screening [26]. Furthermore, transgenes delivered by
lentiviral vectors integrate as individual molecules in the chromo-
some, and thus are not subject to repeat-induced silencing. Our
transgenic Cre lines provided reproducible recombination in the
same subset of neurons within a mouse line carrying a single
insertion, and each line revealed a distinct subset of cells. In the
future, it should be possible to combine enhancer trapping with
germline transposition [27] to facilitate the generation of trans-
genic lines with different integration sites that would label a high
number of neuronal subsets.
Figure 5. Variability of functional properties in neuronal subsets in thy1mp-cre lines. (A)-(D) Sagittal sections of thy1mp-cre lines (FTC.13
((A), (B)) and FTC.08 ((C), (D)) reveal changes in the layer-specific expression in the frontal versus occipital cortical areas. In addition, in the occipital
cortex the layer-specific expression changed from medial ((A), (C) corresponding to retrosplenial cortex) to lateral ((B), (D) corresponding to visual
cortex) (bar=1 mm). (E) Whole-cell recordings from visual cortex layer 2/3 of thy1mp-cre line FTC.08 were performed from GFP positive and GFP
negative neurons in the same animals (n=7 and 11, respectively). The relationship between the amount of injected current and the frequency of
induced action potential was plotted for each recorded cell. GFP positive layer 2/3 neurons from FTC.08 had a smaller variability in their frequency-
current relationship than GFP negative layer 2/3 pyramidal neurons in the same animals. (F) shows the adaptation index for GFP positive and GFP
negative control layer 2/3 pyramidal neurons from line FTC.08 (n=7, 11, respectively). The adaptation index indicates the ratio of the second
interspike interval (ISI) over the last ISI of a series of pulses (200 ms).
doi:10.1371/journal.pone.0038593.g005
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populations identified by this strategy could not be achieved by
transgenic techniques that reproduce the pattern of expression of
endogenous genes. The strategy of enhancer trapping comple-
ments other existing technologies used to genetically identify
neuronal types. Considering the potentially widespread applica-
tion in cellular and system analysis with optical, electrophysiolog-
ical, and genetic manipulations, this transgenic strategy could be
used to provide an ‘off-the-shelf’ library of mouse lines specific for
neuronal subsets. In the future, this transgenic approach could also
be extended to other organisms of neurobiological interest such as
rats and birds that are now easily accessible to transgenic
manipulations [26,28].
Methods
Generation of Enhancer Detector Constructs
The lentiviral vectors used for enhancer detection were based
on our previously described lentiviral backbones that allow us to
achieve high viral titers and high levels of expression [26,29]. We
introduced the human heat shock gene 68 (HSP68) minimal
promoter consisting of 226 base pairs upstream from the
transcription start site [12] into the FW backbone [26,29]. This
minimal promoter lacks enhancer activity and does not produce
detectable transcription when introduced to cells as an episomal
element. The reporter gene nlacZ, which contains a nuclear
localization sequence, was placed downstream of the promoter.
The same backbone was used to create the FTC lines, using the
310 base pair minimal promoter of the Thy-1.2 gene and
a Cre:GFP fusion as the reporter gene (thy1mp-cre).
Generation of Transgenic Mice with Enhancer Probes
Transgenic mice were produced as described before [26] by
delivering concentrated lentiviral vectors into the perivitelline
space. All procedures were approved by the local animal
committees.
Southern Blotting
All F0 transgenic mice were analyzed by Southern blot. Hsp68-
nlacZ mice with multiple copies were crossed to CD-1 mice and
subsequent generations also were examined by Southern to isolate
single-copy insertions. F0 thy1mp-cre mice with 1–4 copies were
crossed to homozygote Z/EG reporter mice, again with the F1
progeny analyzed by Southern to identify single-copy animals.
Identification of Insertion Sites
In order to clone pieces of genomic DNA flanking the insertion
site of the probe we performed ligation-mediated PCR (LM-PCR)
from the genomic DNA of transgenic mice carrying single copies
[30].
Expression Patterns of Transgenic Mice
We analyzed the staining pattern of twenty-five animals
carrying unique single-copy integrations of the hsp68-nlacZ
proviral probe and twenty animals carrying unique integrations
of the enhancer probe in fixed 50 mm thick sections. Mice were
perfused transcardially with PBS and then 3% paraformaldehyde
in PBS; brains were postfixed overnight at 4uC. Tissue was stained
with an X-gal solution for animals expressing nlacZ or immuno-
fluorescently stained with a rabbit polyclonal antibody raised
against GFP (1:4000, Chemicon) or a monoclonal antibody raised
against Cre (1:1000, Chemicon) and A488/555-conjugated
secondary antibodies (Molecular Probes).
Fluorescence-guided Recordings
Coronal 350 mm brain slices were prepared from the visual
cortex of P45-P60 mice with a solution containing (in mM): 212
sucrose, 3 KCl, 1.25 NaH2PO4, 26 NaHCO3, 7 MgCl2,1 0
glucose, and pH 7.3 at 4uC. Slices were recovered for 30 min at
35uC in ACSF containing (in mM): 125 NaCl, 2.5 KCl,
1.25 NaH2PO4, 26 NaHCO3, 1 MgCl2, 2 CaCl2, 20 glucose,
and pH 7.3. Fluorescence-guided whole-cell recordings (Heka
EPC-10) were performed at 22uC with pipette solution contain-
ing (in mM): 2 NaCl, 4 KCl, 130 K-gluconate, 10 HEPES, 0.2
EGTA, 4 ATP-Mg, 0.3 GFP-tris, 14 phosphocreatine, 0.02
Alexa555 hydrazide, and pH 7.3. Patch pipettes had 7 to
9 MOhm resistance. In the whole-cell configuration, either
current steps of 5 ms (0.2–0.4 nA) were elicited to evoke single
action potentials, or longer, incrementing current steps (200 ms)
were applied to measure interspike intervals (ISI). The adaptation
index indicates the ratio of the second ISI over the last ISI of
a series of pulses (200 ms), and the frequency-current relationship
was obtained plotting the action potential frequency during
a 200 ms pulse against the injected current. Finally, overlay of
GFP fluorescence and Alexa555 dye was confirmed. Biocytin fills
(2–4 mg/ml intracellular solution, Sigma) were incubated with
1% avidin-biotinylatedhorseradish peroxidase complex contain-
ing 0.1% Triton X-100 (ABC-Elite) and then reacted using 3,3-
diaminobenzidine(Pierce).
Ethics Issues
No humans participants were involved in this study. Ethics
approval by a committee was not necessary. The experiments
involving animals were approved by the IACUC committee of the
Massachusetts Institute of Technology.
Supporting Information
Figure S1 Consistent recombination patterns in trans-
genic mice carrying a Cre-expressing enhancer probe.
(A) Recombination patterns for GFP expression were consistent
among animals with the same insertion site of thy1mp-cre. (A1)–
(A3) show the dorsal hippocampi of three animals from the
FTC.03 line. They shared the same expression pattern (bar=500
mm). (B) In this transgenic line the persistent cre expression was
consistent in three adult animals ((B1)-(B3)). In all animals the
persistent cre expression in the adult was much smaller than the
density of recombined GFP-positive neurons (bar=500 um).
(TIF)
Figure S2 Variability of functional properties in neu-
ronal subsets in thy1mp-cre lines. (A) Recording site in the
visual cortex (V1 area) for GFP positive and GFP negative control
layer 2/3 pyramidal neurons from line FTC.08. (B) Biocytin-filled
GFP positive and GFP negative control layer 2/3 pyramidal
neurons from line FTC.08 (bar=25 mm). (C) Action potential
width and action potential rise time had different variability for
GFP positive and GFP negative control layer 2/3 pyramidal
neurons from line FTC.08 (n=7, 11, respectively). A single action
potential was evoked by 5 ms current step to measure the action
potential width and action potential rise time GFP positive and
GFP negative control layer 2/3 pyramidal neurons from line
FTC.08 had similar membrane time constants (37.361.4 ms and
36.663.2 ms, respectively) and resting membrane potentials
(272.962.1 ms and 272.261.3 mV, n=7 and 11, respectively).
(TIF)
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